Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4

Inhibition of cancer-promoting kinases is an established therapeutic strategy for the treatment of many cancers, although resistance to kinase inhibitors is common. One way to overcome resistance is to target orthogonal cancer-promoting pathways. Bromo and Extra-Terminal (BET) domain proteins, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Bryce K., Mehta, Saurabh, Ember, Stewart W. J., Schonbrunn, Ernst, Ayad, Nagi, Schürer, Stephan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657038/
https://www.ncbi.nlm.nih.gov/pubmed/26596901
http://dx.doi.org/10.1038/srep16924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657038/
https://www.ncbi.nlm.nih.gov/pubmed/26596901
http://dx.doi.org/10.1038/srep16924

Ejemplares similares